Abstract
SNP-1, a nasal inhalation capsule containing eucalyptus essence and levogyral menthol, was used to see whether it improves snoring or not.
The subjects were 30 patients with snoring, consisting of 20 males and 10 females, and their mean age was 46.1 years.
The improvement was excellent in 2 patients, fair in 7 patients, moderate in 10 patients and poor in 11 patients.
None of these patients had any side effects of the drug.
SNP-1 can be considered to be an appropriate drug for moderate and mild snoring patients as conservative treatment.
